Learn how Beverly Hills’ leading dermatologist began working with stem cells and investigating their language, or as he calls it, consortia factors, and how these can be used for skin rejuvenation.

In this episode of RegenaCast, Sean sits down with Dr. Nathan Newman, a renowned dermatologist and pioneer in the field of regenerative medicine, particularly in stem cell therapy and exosome treatments. Dr. Newman’s journey into facial fat transfer and working with stem cells began early in his career when he realized the transformative potential of fat cells. Over time, he developed a technique to concentrate stem cells from fat and observed remarkable improvements in skin quality and texture that occurred much faster than typical fat grafting results.
Dr. Newman explains how he discovered that these improvements weren’t solely due to the fat or the cells themselves, but rather the secretions—growth factors and cytokines—released by the stem cells, also known as consortia factors. These factors have the ability to communicate with cells, essentially directing tissue regeneration in a more targeted and efficient manner.
Dr. Newman also discusses the growing interest in exosomes and how they fit into regenerative medicine. While exosomes package specific signals from cells, Dr. Newman believes that consortia factors, which are more complete and stable, offer a more holistic and powerful approach to tissue repair and regeneration.
The conversation dives into the potential applications of these factors for wound healing, burns, and even hair restoration, though Dr. Newman acknowledges that fully regenerating lost hair follicles remains a challenge. He shares how his work with regenerative skincare products has led to the development of STEM, a product line designed to turn back the clock on aging skin, offering faster, more directed rejuvenation.
If you’re intrigued by regenerative medicine and want to hear more, don’t forget to attend the Cell Surgical Conference Las Vegas this June! It’s a great opportunity for professionals and those interested in cutting-edge stem cell therapies and more.